GlassScriptPhysician profile
Amanda M Ode
NPI 1154820231
$11,111.49
in general payments reported to CMS, 2019-2025
37 companies · $4,595 in 2025
The $4,595 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $533 · 2022: $364 · 2023: $1,612 · 2024: $4,008 · 2025: $4,595.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,215.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,464.12 | 2022-2025 | Tepezza, Repatha, Otezla |
| Abbott Laboratories | $1,155.70 | 2021-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $1,121.51 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Insulet Corporation | $1,096.60 | 2021-2025 | Omnipod, Omnipod |
| Sanofi-Aventis U.S. LLC | $723.81 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $523.29 | 2023-2025 | Jardiance |
| Corcept Therapeutics | $497.87 | 2024-2025 | Korlym |
| Tandem Diabetes Care, INC. | $462.81 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Novo Nordisk INC | $431.08 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Sequel Med Tech, LLC | $411.51 | 2025 | Twiist |
| Dexcom, INC. | $404.10 | 2021-2025 | Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Mannkind Corporation | $391.19 | 2024-2025 | |
| Ascensia Diabetes Care US INC. | $368.81 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $358.48 | 2023-2025 | |
| Abbvie INC. | $179.39 | 2024-2025 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $160.06 | 2024 | Strensiq |
| Recordati_rare_diseases_inc. | $138.41 | 2024-2025 | Isturisa, Signifor Lar |
| Amneal Pharmaceuticals LLC | $134.14 | 2024-2025 | Unithroid |
| Madrigal Pharmaceuticals | $124.72 | 2025 | Rezdiffra |
| Amphastar Pharmaceuticals, INC. | $116.95 | 2025 | |
| Glaxosmithkline, LLC. | $113.07 | 2023 | Shingrix |
| Soleno Therapeutics, INC. | $94.15 | 2025 | Vykat Xr |
| Kyowa Kirin, INC. | $79.04 | 2024-2025 | Crysvita |
| Ibsa Pharma INC. | $70.23 | 2024-2025 | Tirosint, Licart, Flector |
| Xeris Pharmaceuticals, INC. | $62.54 | 2025 | Recorlev |
| Medtronic, INC. | $60.46 | 2024-2025 | Minimed 780g |
| Chiesi USA, INC. | $60.00 | 2024-2025 | Mycapssa, Myalept |
| Ascendis Pharma Endocrinology INC | $50.60 | 2024-2025 | Yorvipath |
| Novartis Pharmaceuticals Corporation | $44.01 | 2024-2025 | |
| Almatica Pharma LLC | $42.08 | 2024 | Teriparatide, Loreev Xr |
| Astrazeneca Pharmaceuticals LP | $33.66 | 2025 | Airsupra |
| Merck Sharp & Dohme LLC | $25.59 | 2024 | Capvaxive, Gardasil 9, Gardasil |
| Pfizer INC. | $25.14 | 2025 | |
| Radius Health, INC. | $24.78 | 2025 | |
| Rhythm Pharmaceuticals, INC. | $24.45 | 2025 | Imcivree |
| Amryt Pharma Holdings LTD | $18.98 | 2023 | Mycapssa |
| Exact Sciences Corporation | $18.16 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Ode listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.